Piramal Pharma Acquires Yapan Bio
Piramal Pharma strengthens its biologics CDMO business, converting Yapan Bio from associate company to subsidiary and expanding vaccine and biologics manufacturing capabilities.
Pharma
Cancer Vaccines Get Their First Real Win
The first personalized mRNA cancer therapy to beat the standard of care is now headed for regulators.
Modular Automation Moves from Vision to GMP Reality
A pharma project demonstrates how MTP can accelerate integration while reducing validation effort.
Eurofins CDMO Alphora Expands Capacity and HPAPI Capabilities
Eurofins CDMO Alphora has expanded its kilolab and high-potency active pharmaceutical ingredient (HPAPI) development and manufacturing capabilities in Ontario.
Novo Nordisk Partners with Amazon to Boost Drug Discovery
Novo Nordisk and Amazon Web Services (AWS) have partnered to accelerate drug discovery with AI. A co-innovation hub in London will facilitate efforts to reduce the time to market for future medicines.
Cambrex Milan Constructs New $30 Million R&D Facility; Celebrates 80th Anniversary
CDMO Cambrex started construction on a new R&D facility at its Milan, Italy site. The $30 million investment adds advanced analytical development and process R&D capabilities.
Bristol Myers Squibb Invests $2.3 Billion in Houston Campus
The investment furthers the company's $40 billion commitment to invest in American innovation and manufacturing.
Mabion and KriSan Biotech Launch Partnership for Next-Gen ADCs
The partners will combine their unique capabilities to jointly develop, offer, and deliver integrated services in the Antibody-Drug Conjugates (ADC) segment for the global pharmaceutical and biotechnology industries.
Bachem to Build Large-scale Production Facility in Switzerland
The next phase of expansion for the Greenfield project in Sisslerfeld (Eiken, Switzerland) will be carried out as part of a strategic partnership. The total investment amounts to more than 500 million CHF.
Lonza and Engitix Announce License Agreement to Advance Targeted ADC Development
Agreement advances new therapies through Engitix’s unique focus on the extracellular matrix (ECM).
Brenntag Pharma Enters into a Strategic Partnership with Evonik
An exclusive distribution agreement for Evonik Rexim amino acids strengthens Brenntag's role in the biopharma and API markets.
How FDA's PreCheck Pilot Aims to Speed Up US Drug Manufacturing
DCAT reports that FDA has selected seven companies for its new PreCheck Pilot Program, designed to encourage US-based drug manufacturing through earlier engagement and a more predictable regulatory path.
Olon Expands Concord, Ohio Site, Doubling US Manufacturing Capacity
Olon has completed a major expansion at its Concord, Ohio facility, doubling production capacity and strengthening the site's role as a US manufacturing hub within its global development network.
Fujifilm Biotechnologies Selected for FDA PreCheck Pilot Program to Advance US Drug Manufacturing
Fujifilm Biotechnologies' Holly Springs, NC facility has been chosen as one of seven participants in the FDA's PreCheck Pilot Program, aimed at strengthening US pharmaceutical manufacturing and regulatory readiness.
Innexis Acquires Novartis's Kundl Site
Innexis plans to acquire the multi-user facility in Kundl, Tyrol, from Novartis.
Siddharth Mittal Appointed as Managing Director & CEO of Syngene International
Syngene International announced that Siddharth Mittal has assumed the role of Managing Director and Chief Executive Officer of the Company, effective 1 July 2026.
Symeres and Axxam Unite Drug Discovery Platforms Under Single Scientific Chief
Russell Thomas, who has held senior roles at both organisations, takes on the joint CSO position as Symeres and Axxam push to offer clients a single pipeline spanning target screening to IND-ready drug candidates.
Former Bachem Executive Torsten Woehr to Become CEO of Rentschler
Rentschler Biopharma has appointed Torsten Woehr as Chief Executive Officer (CEO), effective August 1, 2026.
Adragos and Towa to Produce 1.5 Billion Tablets a Year
CDMO Adragos Pharma Kawagoe and Towa Pharmaceutical have agreed to a manufacturing partnership that will nearly triple solid-dosage capacity, shoring up Japan's fragile generics supply chain.
Neuland to Open $20m Process Development Facility in Hyderabad
Neuland Laboratories will open a dedicated process development lab and integrated kilo lab at its Genome Valley campus in Hyderabad, India.
Lonza Expands Visp Site to Meet Demand in ADCs
Lonza to expand payload-linker manufacturing capacity in Visp (CH) to support the rapidly growing antibody-drug conjugate (ADC) market.
Digitalization as a Strategic Lever in R&D
Digital Innovation: a key driver of competitiveness and sustainability across the pharmaceutical industry.
Elevating AI-Driven Discovery: Simplifying Complexity with CDD Vault
Drug discovery generates enormous amounts of data, but turning it into meaningful insight is a major challenge.
Pharma 4.0: Big Promises, Poor Data - What’s Going Wrong?
Pharma 4.0 is high on every strategic agenda. Yet many struggle to turn digital ambitions into measurable results. Projects stall, systems don’t align, and valuable insights remain locked in fragmented data structures.
The Hidden Cost of How Chemical Companies Experiment
Smart Experimentation - why the combination of Design of Experiments and Bayesian Optimization with intuitive analytics is the most important productivity lever your R&D organization isn't using
Closing the Gap Between Lab and Production
Shorter development cycles and complex active ingredients are demanding integrated solutions. Guided by the principle "Together – from lab to production," Fette Compacting positions its R&D Solutions as a partnership.
AI as a Game Changer
How Artificial Intelligence is transforming the work of biotech and pharma companies.
Lonza Issues License to Antharis Therapeutics for ADCs
Lonza and Antharis Therapeutics announced an exclusive, target-specific licensing agreement to develop novel dual-payload ADCs targeting gastrointestinal (GI) cancers.
Recipharm Expands US Sterile Fill and Finish Capabilities
Recipharm announced a multi-million-dollar investment in its US operations, strengthening its ability to support pharma and biotech companies with advanced sterile fill and finish services.
Chiesi Group Acquires KalVista Pharmaceuticals for $1.9 Billion
Chiesi Group has completed its acquisition of KalVista Pharmaceuticals, marking the Italian biopharmaceutical group's largest deal to date.
Siegfried Inaugurates Pharma API plant in Minden
Siegfried has inaugurated a new large-scale API production facility at its German site in Minden.
GSK Strikes $10.6 Billion Deal for Nuvalent in One of Pharma's Biggest Oncology Acquisitions of 2026
GSK has agreed to acquire US clinical-stage oncology specialist Nuvalent for $10.6 billion, its largest deal in years, to accelerate entry into lung cancer and boost growth through the dolutegravir patent cliff.
Axplora Repositions European Site on High-Potency Drugs as India Takes Over UDCA Production
Axplora is repositioning its Italian Farmabios site on high-potency APIs as UDCA production moves to its FDA-approved Vizag facility in India, consolidating supply and scaling for global demand.
Eli Lilly and Boehringer Ingelheim Cancel Investments
A clear signal to Berlin: the pharmaceutical companies Eli Lilly and Boehringer Ingelheim are canceling planned investments in Germany.
Sygnature Discovery Collaborates with DaltonTx to Advance AI-enabled Drug Discovery
Sygnature Discovery has partnered with AI firm DaltonTx to sharpen its drug discovery pipeline, bringing faster medicinal chemistry decisions and tighter data privacy to its CRO offering.
